59 related articles for article (PubMed ID: 1886955)
1. [Adverse effects of long-term psychopharmacologic therapy on sexual functions].
Pfeiffer W; Kockott G; Fischl B; Schleuning G
Psychiatr Prax; 1991 May; 18(3):92-8. PubMed ID: 1886955
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts.
Teusch L; Scherbaum N; Böhme H; Bender S; Eschmann-Mehl G; Gastpar M
Pharmacopsychiatry; 1995 May; 28(3):84-92. PubMed ID: 7568370
[TBL] [Abstract][Full Text] [Related]
3. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Byerly MJ; Nakonezny PA; Rush AJ
Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
[TBL] [Abstract][Full Text] [Related]
4. Lateral ventricular size, psychopathology, and medication response in the psychoses.
Luchins DJ; Lewine RR; Meltzer HY
Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730
[TBL] [Abstract][Full Text] [Related]
5. Sexual disorders in nonacute psychiatric outpatients.
Kockott G; Pfeiffer W
Compr Psychiatry; 1996; 37(1):56-61. PubMed ID: 8770528
[TBL] [Abstract][Full Text] [Related]
6. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
7. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
Banov MD; Zarate CA; Tohen M; Scialabba D; Wines JD; Kolbrener M; Kim JW; Cole JO
J Clin Psychiatry; 1994 Jul; 55(7):295-300. PubMed ID: 8071290
[TBL] [Abstract][Full Text] [Related]
8. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
9. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
10. [Psychotropic drug-induced changes in sexuality--frequency and relevance in psychiatric practice].
Strauss B; Gross J
Psychiatr Prax; 1984 Mar; 11(2):49-55. PubMed ID: 6718602
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
12. Sexual problems in a sample of the Turkish psychiatric population.
Hariri AG; Karadag F; Gurol DT; Aksoy UM; Tezcan AE
Compr Psychiatry; 2009; 50(4):353-60. PubMed ID: 19486734
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
14. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
[TBL] [Abstract][Full Text] [Related]
15. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia.
Ito C; Kubota Y; Sato M
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S35-40. PubMed ID: 10560896
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
17. Treatment of supersensitivity psychosis with antiepileptic drugs: report of a series of 43 cases.
Chouinard G; Sultan S
Psychopharmacol Bull; 1990; 26(3):337-41. PubMed ID: 2274634
[TBL] [Abstract][Full Text] [Related]
18. [Social integration of long-term paraphrenic patients with low-dose depot neuroleptic medication].
Lesch OM; Dietzel-Rogan M; Musalek M; Rajna P; Rustembegovich A; Schjerve M; Walter H
Psychiatr Prax; 1985 Mar; 12(2):63-8. PubMed ID: 3887443
[TBL] [Abstract][Full Text] [Related]
19. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
20. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.
Gaertner I; Gilot C; Heidrich P; Gaertner HJ
Pharmacopsychiatry; 2002 Mar; 35(2):37-43. PubMed ID: 11951144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
